We firstly detected the low expression of CBL in GC cell lines (BGC‐823, MKN‐28, MKN‐45, AGS and SGC‐7901) compared with GES‐1 in mRNA and protein expression levels (Figure 4B), implying the potential role in tumour inhibition. The gene discussed is CBL; the disease is neoplasm.